Arkolith/Insider Trading/BCRX/Form 4

Barnes Alane P

Chief Legal OfficerBIOCRYST PHARMACEUTICALS INC (BCRX) · full profile →Form 4 · filed May 15, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$596K
Net Open-Market Flow
-$596K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 13, 2026Option exercise(M)63K$5.04$315K463K
May 13, 2026Sell(S)63K$9.54$596K401K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 13, 2026Option exercise(M)63K—$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000882796-26-000021) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML